ALNY vs AMBA · P/E 76, rev $1.29B vs rev $208.5M
Alnylam Pharmaceuticals Inc (ALNY) versus Ambarella Inc (AMBA) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Ambarella Inc (AMBA) is a semiconductor equipment & materials company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported AMBA revenue for 2026-07-31 was $208.5M. Net income was -$24.8M. AMBA currently screens at market cap $2.86B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. AMBA currently screens at market cap $2.86B.
Not investment advice. Open the ALNY and AMBA stock pages for the full models.
Not investment advice.